In colon cancer, the micropeptide HOXB-AS3 inhibits PKM2 isoform production and reprogrammes glucose metabolism by blocking hnRNP A1-dependent PKM splicing, miR-18a processing, and thus CRC growth [101]. The gene discussed is PKM; the disease is malignant colon neoplasm.